Business & Economics
Prostate Cancer
100%
Cost-effectiveness
85%
Systematic Review
84%
Radiation
63%
Therapy
48%
Quality-adjusted Life Years
17%
Costs
11%
Cost-effectiveness Analysis
11%
Surgery
8%
Cost-utility Analysis
6%
Cost-effectiveness Ratio
6%
Medicare
5%
Incremental Cost
5%
Registry
5%
Morbidity
5%
Cost Analysis
4%
Side Effects
4%
Decision Analysis
4%
Costing
4%
Reimbursement
4%
Sensitivity Analysis
3%
Data Base
3%
Canada
3%
Uncertainty
2%
United States of America
1%
Medicine & Life Sciences
Cost-Benefit Analysis
52%
Prostatic Neoplasms
48%
Systematic Reviews
45%
Radiotherapy
42%
Costs and Cost Analysis
31%
Proton Therapy
27%
Prostate
25%
Quality-Adjusted Life Years
16%
Radiosurgery
11%
Brachytherapy
11%
Radiation
7%
Technology
6%
Decision Support Techniques
6%
Watchful Waiting
5%
Medicare
5%
Uncertainty
4%
Canada
4%
PubMed
4%
Registries
4%
Therapeutics
3%
Databases
3%
Morbidity
3%
Social Sciences
costs
34%
surgery
5%
driver
4%
utility analysis
4%
life years
3%
literature
2%
new technology
2%
uncertainty
2%
Canada
1%
time
0%